These include Annexin A6 (ANXA6) and CD146/Melanoma cell adhesion molecule (MCAM), which were reported to promote radioresistance in nasopharyngeal carcinoma [30] and glioblastoma multiforme [31], respectively. This evidence concerns the gene MCAM and nasopharyngeal carcinoma.